ELSSF yields 1.77% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ELSSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELSSF + PFE for your $10,000?
Elis SA provides linen and work wear textile, hygiene, and well-being services in France, the United Kingdom, Ireland, Central Europe, Scandinavia, Eastern Europe, Southern Europe, Latin America, and internationally. The company offers table, kitchen, and hotel linens; workwear and personal protective equipment; floor protection mats, mops, and wiping cloths; industrial wipers; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; and pest control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, lavatories, air fragrancing, toilet hygiene and urinal, and feminine hygiene; and reusable cleanroom garments, footwear, goggles, logistics, and related contamination control solutions, as well as cleaning systems. In addition, the company offers medical waste collection, management, and disposal services, as well as personal laundry services for residential facilities, daycares, and schools. It primarily serves the catering, accommodation, healthcare and welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Full ELSSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.